Marco Cavaleri, Head of Anti-infectives and Vaccines, Scientific and Regulatory management Department at EMA, is responsible for the management of pre- and post-authorisation activities of centralised applications/marketing authorisations, and particularly the Safety and Efficacy part, related to medicinal products in the above-mentioned therapeutic areas.
Marco Cavaleri is a Pharmacologist who spent several years in industry in R&D mainly in the area of antibacterials and antifungals covering different positions in preclinical and clinical development.
In 2005 he joined the EMEA as Scientific Administrator in the Scientific Advice and Orphan Drugs Sector, specifically being in charge of anti-infectives and vaccines scientific advice procedures.
He returned to the Agency in 2008 as Group Leader Anti-infectives in the Safety&Efficacy Sector, Pre-Authorisation Human Unit following a short period in industry leading clinical and preclinical development in the area of Gastroenterology and Infectious Diseases. In 2009 he was appointed as Head of Section for Anti-infectives and vaccines in the Safety&Efficacy Sector, Human Medicines Development and Evaluation Unit.